Expression of Fos-related antigens in the nucleus accumbens during opiate withdrawal and their attenuation by a D2 dopamine receptor agonist

被引:24
|
作者
Walters, CL [1 ]
Aston-Jones, G [1 ]
Druhan, JP [1 ]
机构
[1] Univ Penn, Med Ctr, Ctr Neurobiol & Behav, Dept Psychiat, Philadelphia, PA 19104 USA
关键词
nucleus accumbens; Fos-related antigens; dopamine receptors; opiate withdrawal; morphine; drug abuse;
D O I
10.1016/S0893-133X(00)00113-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Previous studies from this laboratory indicated that D2 dopamine (DA) receptors within the nucleus accumbens (NAc) are important for regulating somatic signs of opiate withdrawal. The present study measured the expression of Fos-related antigens (FRAs) within the NAc during opiate withdrawal to determine whether decreases in somatic withdrawal signs produced by a D2 receptor agonist are accompanied by related changes in accumbens neuronal activity. In an initial experiment, quantitative analyses of FRA immunoreactivity revealed increases in the number of FRA-positive cells throughout the NAc of opiate dependent animals undergoing naltrexone-precipitated withdrawal relative to dependent or non-dependent animals that did not experience withdrawal. A second experiment showed that somatic signs and FRA expression within the NAc could each be attenuated when the D2 agonist propylnorapomorphine (NPA; 0.1 or 0.3 mg/kg, i.p.) was administered prior to naltrexone-precipitated withdrawal. These findings suggest that D2 regulation or neuronal activity within the NAc may be important for the expression of opiate withdrawal symptoms. (C) 2000 American College of Neuropsychopharmacology. Published by Elsevier Science Inc. All rights reserved.
引用
收藏
页码:307 / 315
页数:9
相关论文
共 50 条
  • [41] The regulation of D2 dopamine receptor expression
    R J Hitzemann
    Molecular Psychiatry, 1998, 3 : 198 - 203
  • [42] Increased Dopamine Receptor Activity in the Nucleus Accumbens Shell Ameliorates Anxiety during Drug Withdrawal
    Anna K Radke
    Jonathan C Gewirtz
    Neuropsychopharmacology, 2012, 37 : 2405 - 2415
  • [43] Increased Dopamine Receptor Activity in the Nucleus Accumbens Shell Ameliorates Anxiety during Drug Withdrawal
    Radke, Anna K.
    Gewirtz, Jonathan C.
    NEUROPSYCHOPHARMACOLOGY, 2012, 37 (11) : 2405 - 2415
  • [44] The regulation of D2 dopamine receptor expression
    Hitzemann, RJ
    MOLECULAR PSYCHIATRY, 1998, 3 (03) : 198 - 203
  • [45] Normal opiate reward in dopamine D2 receptor knockout mice
    Dockstader, CL
    van der Kooy, D
    Rubinstein, M
    Grandy, DK
    Low, MJ
    BRAIN RESEARCH, 1998, 809 (01) : U8 - U8
  • [46] Negative interaction of dopamine D2 receptor antagonists and GBR 12909 and GBR 12935 dopamine uptake inhibitors in the nucleus accumbens
    Rahman, S
    Engleman, E
    Simon, J
    McBride, WJ
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 414 (01) : 37 - 44
  • [47] Dopamine transmission at D1 and D2 receptors in the nucleus accumbens contributes to the expression of incubation of cocaine craving
    Weber, Sophia J.
    Kawa, Alex B.
    Beutler, Madelyn M.
    Kuhn, Hayley M.
    Moutier, Alana L.
    Westlake, Jonathan G.
    Koyshman, Lara M.
    Moreno, Cloe D.
    Wunsch, Amanda M.
    Wolf, Marina E.
    NEUROPSYCHOPHARMACOLOGY, 2024, 50 (02) : 461 - 471
  • [48] Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic
    Keck, PE
    McElroy, SL
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (04) : 655 - 662
  • [49] Discovery of a true bivalent dopamine D2 receptor agonist
    Qian, Mingcheng
    Ricarte, Adrian
    Wouters, Elise
    Dalton, James A. R.
    Risseeuw, Martijn D. P.
    Giraldo, Jesus
    Van Calenbergh, Serge
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 212
  • [50] Reverse microdialysis of a dopamine D2 receptor antagonist alters extracellular adenosine levels in the rat nucleus accumbens
    Nagel, J
    Hauber, W
    NEUROCHEMISTRY INTERNATIONAL, 2004, 44 (08) : 609 - 615